Inventor · disambiguated record
Markus Tschoepe
Also filed as: TSCHOEPE MARKUS
6 granted patents·11 pending applications·466 citations·filing 2008–2022
87Inventor score
Top patents by PatentIndex Score
17 records- 0197US9085619B2Anti-TNF antibody formulationsABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 21, 2015·83 cites·30 claims
- 0296US8883146B2Protein formulations and methods of making sameABBVIE INC·Filed 2013·Granted Nov 11, 2014·102 cites·18 claims
- 0395US8420081B2Antibody formulations and methods of making sameFRAUNHOFER WOLFGANG·Filed 2008·Granted Apr 16, 2013·165 cites·135 claims
- 0491US8821865B2High concentration anti-TNFα antibody liquid formulationsNEU MICHAEL·Filed 2011·Granted Sep 2, 2014·116 cites·11 claims
- 0575US11191834B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Dec 7, 2021·0 cites·20 claims
- 0675US11167030B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Nov 9, 2021·0 cites·20 claims
- 0773US2019358322A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 0869US2022010005A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 0967US2017143828A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2017·Application pending·0 cites
- 1063US2015361170A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 1163US2020282072A1Anti-egfr antibody drug conjugate formulationsABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1261US2016222101A1Protein formulations and methods of making sameABBVIE INC·Filed 2016·Application pending·0 cites
- 1359US2019211093A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 1459US2014377275A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1558US2023007847A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2022·Application pending·0 cites
- 1651US2014286969A1Anti-egfr antibody drug conjugate formulationsABBVIE INC·Filed 2014·Application pending·0 cites
- 1750US2016017030A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →